List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Human medicines European public assessment report (EPAR): Nuceiva, botulinum toxin type a, Skin Aging, Date of authorisation: 27/09/2019, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Meningitis, Meningococcal, Date of authorisation: 24/05/2017, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Riximyo, rituximab, Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Microscopic Polyangiitis;Wegener Granulomatosis, Date of authorisation: 15/06/2017, Revision: 14, Status: Authorised
Etoposide : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001333/202302
Etoposide : List of nationally authorised medicinal products - PSUSA/00001333/202302
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Lymphoma, Non-Hodgkin;Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 13/07/2017, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Rixathon, rituximab, Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell;Wegener Granulomatosis;Microscopic Polyangiitis;Pemphigus, Date of authorisation: 15/06/2017, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Trizivir, abacavir (as sulfate) / lamivudine / zidovudine, HIV Infections, Date of authorisation: 27/12/2000, Revision: 43, Status: Authorised